Tumour size as a predictor of axillary node metastases in patients with breast cancer

ANZ Journal of Surgery

Volumn 76, Issue 11, 2006, Pages 1002-1006

  Laura, Sharon ^a   Coombs, Nathan J ^a   Ung, Owen ^a   Boyages, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Axilla; Breast neoplasm; Lymph node excision; Neoplasm metastasis; Projection and prediction

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PATIENT; DECISION MAKING; FEMALE; HISTOLOGY; HUMAN; LINEAR REGRESSION ANALYSIS; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREOPERATIVE PERIOD; PROBABILITY; SURGEON; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33750061905     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2006.03918.x     Document Type: Article

References (21)

1. Axelsson CK, Mouridsen HT, Zedeler K. Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur. J. Cancer 1992; 28: 1415-18.
2. Beenken SW, Urist MM, Zhang Y et al. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann. Surg. 2003; 237: 732-8.
3. Axelsson CK, Rank F, Blichert-Toft M, Mouridsen HT, Jensen MB. Impact of axillary dissection on staging and regional control in breast tumors ≤10 mm - the DBCG experience. The Danish Breast Cancer Cooperative Group (DBCG), Rigshisoutalet, Copenhagen, Denmark. Acta Oncol. 2000; 39: 283-9.
4. Grills IS, Kestin LL, Goldstein N et al. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes. Int. J. Radiat. Oncol. Biol. Phys. 2003; 56: 658-70.
5. Weir L, Speers C, D'yachkova Y, Olivotto IA. Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J. Clin. Oncol. 2002; 20: 1793-9.
6. Carter C, Allen C, Henson DE. Relation of tumour size, lymph node status and survival in 24 740 breast cancer cases. Cancer 1989; 63: 181-7.
7. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J. Surg. 2001; 25: 767-72.
8. Chua B, Ung O, Taylor R, Boyages J. Frequency and predictors of axillary node metastases in invasive breast cancer. ANZ J. Surg. 2001; 71: 723-8.
9. Tabar L, Duffy SW, Vitak B, Chen H-H, Prevost TC. The natural history of breast carcinoma. What have we learnt from screening? Cancer 1999; 86: 449-62.
10. Lagios MD, Westdahl PR, Rose MR. The concept and implications of multicentricity in breast carcinoma. In: Sommers S, Rosen P (eds). Pathology Annual. New York: Appleton-Century-Crofts, 1981; 83-102.
11. Holland R, Veling SH, Mravunac M, Hendriks JH. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985; 56: 979-90.
12. American Joint Committee on Cancer. Breast AJCC Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, 1997; 127-33.
13. Andea AA, Wallis T, Newman LA, Bouwman D, Dey J, Visscher DW. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer 2002; 94: 1383-90.
14. Andea AA, Bouwman D, Wallis T, Visscher DW. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer 2004; 100: 20-27.
15. Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch. Pathol. Lab. Med. 2003; 127: 701-5.
16. Lambah PA, McIntyre MA, Chetty U, Dixon JM. Imprint cytology of axillary lymph nodes as an intraoperative diagnostic tool. Eur. J. Surg. Oncol. 2003; 29: 224-8.
17. Jannink I, Fan M, Nagy S, Rayudu G, Dowlatshahi K. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann. Surg. Oncol. 1998; 5: 310-14.
18. Sloane JP, Ellman R, Anderson TJ et al. Consistency of histopathological reporting of breast lesions detected by screening: findings of the U.K. National External Quality Assessment (EQA) Scheme. U.K. National Coordinating Group for Breast Screening Pathology. Eur. J. Cancer 1994; 30: 1414-19.
19. Abner AL, Collins L, Peiro G et al. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer 1998; 83: 2502-8.
20. Heusinger K, Lohberg C, Lux MP et al. Assessment of breast cancer tumor size depends on method, histopathology and tumor size itself. Breast Cancer Res. Treat. 2005; 94: 17-23.
21. Bosch AM, Kessels AG, Beets GL et al. Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours. Eur. J. Radiol. 2003; 48: 285-92.